Feeds

Lab mice deaths cast doubt over RNAi

Setback for powerful therapy?

Intelligent flash storage arrays

A technology that has been lauded as a panacea for many currently incurable diseases has been dealt a blow by researchers. A paper appearing in Nature says mice given RNA interference therapy (RNAi) died of liver failure and other complications.

RNA is a close chemical relative of DNA. While DNA can be thought of as an unchanging leather-bound archive, RNA molecules are more like newspapers – dynamic, throwaway and with different agendas. RNA is the workhorse of biological information.

The principle behind RNAi is to use short double-stranded tracts of RNA as guided missiles, intercepting longer RNA messages which pass on information from DNA, before they can be used to make functioning proteins. It's thought to have developed early in evolution - bacteria use it too - as a means of combating viral infections.

Teams are working on harnessing its power to treat both deadly inherited conditions like Huntington's and infectious disease, such as HIV.

For this latest study, a team at Stanford medical school exposed mice to long-term high doses of RNAi. They tried out 49 different RNAi therapies designed to shut down six different genes in liver cells. 36 of the snippets caused liver injury, and 23 led to death within two months.

For biotech firms pumping millions into the field, the news may bring concerning echoes problems researchers have had fulfilling the potential of similarly promising gene therapy technology, which gave patients cancer in an early trial. Proponents say the study should act as a warning, but does not signal disaster for RNAi.

The Stanford team used an indirect approach to introduce the RNAi – they forced the mice's own cells to build them. The scientists speculate that this may have overloaded the cellular machinery, leading to the liver damage and deaths.

John Maraganore of biotech firm Alnylam Pharmaceuticals, which says it has already safely tested a respitory infection RNAi nasal spray told the NYT: "These data really represent the fundamental limitations of gene therapy, not of RNAi."

The authors of the study also note, despite the mouse deaths, other work they did proving the ability of RNAi to silence errant genes "fuels hope" of a whole new mode of attack against illness. ®

Security for virtualized datacentres

More from The Register

next story
Boffins who stare at goats: I do believe they’re SHRINKING
Alpine chamois being squashed by global warming
What's that STINK? Rosetta probe shoves nose under comet's tail
Rotten eggs, horse dung and almonds – yuck
Comet Siding Spring revealed as flying molehill
Hiding from this space pimple isn't going to do humanity's reputation any good
Experts brand LOHAN's squeaky-clean box
Phytosanitary treatment renders Vulture 2 crate fit for export
Kip Thorne explains how he created the black hole for Interstellar
Movie special effects project spawns academic papers on gravitational lensing
LONG ARM of the SAUR: Brachially gifted dino bone conundrum solved
Deinocheirus mirificus was a bit of a knuckle dragger
prev story

Whitepapers

Choosing cloud Backup services
Demystify how you can address your data protection needs in your small- to medium-sized business and select the best online backup service to meet your needs.
Forging a new future with identity relationship management
Learn about ForgeRock's next generation IRM platform and how it is designed to empower CEOS's and enterprises to engage with consumers.
Security for virtualized datacentres
Legacy security solutions are inefficient due to the architectural differences between physical and virtual environments.
Reg Reader Research: SaaS based Email and Office Productivity Tools
Read this Reg reader report which provides advice and guidance for SMBs towards the use of SaaS based email and Office productivity tools.
Storage capacity and performance optimization at Mizuno USA
Mizuno USA turn to Tegile storage technology to solve both their SAN and backup issues.